STOCK TITAN

Formfactor Inc SEC Filings

FORM NASDAQ

Welcome to our dedicated page for Formfactor SEC filings (Ticker: FORM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to FormFactor, Inc. (NASDAQ: FORM) SEC filings, offering a detailed view of how the semiconductor test and measurement company reports its operations, financial condition, and key corporate events. FormFactor supplies electrical and optical test technologies across the IC life cycle, and its filings explain how this business is structured and financed.

In its periodic reports such as the annual Form 10-K and quarterly Form 10-Q, FormFactor describes its two reportable segments: the Probe Cards segment, which includes probe cards and analytical probes, and the Systems segment, which includes probe stations and thermal sub-systems. These filings also discuss risk factors, segment performance, non-GAAP metrics, and the use of test and measurement technologies by semiconductor manufacturers to improve yield and device performance.

Current reports on Form 8-K highlight material developments. Recent examples include restructuring plans to consolidate manufacturing facilities in California and align cost structure with strategic priorities, the entry into a revolving credit agreement that establishes a multi-year credit facility for working capital and other corporate purposes, and leadership changes at the chief financial officer level. Other 8-K filings furnish earnings press releases that detail revenue, gross margin, net income, and reconciliations between GAAP and non-GAAP results.

Through this page, users can also review filings related to corporate governance, such as amendments to bylaws, and documents that may reference equity compensation, severance plans, or other executive arrangements. Real-time updates from EDGAR ensure that new Forms 10-K, 10-Q, 8-K, and other submissions appear as they are filed. AI-powered summaries help interpret complex sections, highlight segment information, and clarify the impact of items like restructuring charges, credit agreements, and non-GAAP adjustments, so readers can more quickly understand what each filing means for FormFactor’s semiconductor test business.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

FormFactor is asking stockholders to approve several items at its 2026 virtual annual meeting, including electing seven directors, updating its charter for Delaware officer exculpation, an advisory vote on 2025 executive pay, and expanding its 2012 Equity Incentive Plan by 5,000,000 shares.

The company highlights record 2025 revenue of $785 million, up 2.8% from 2024, supported by demand tied to generative AI, high‑bandwidth memory, and co‑packaged optics. Management reports non‑GAAP gross margin improvement through cycle‑time and yield gains, a 2026-focused restructuring, a new low‑cost Texas manufacturing facility, and the Keystone Photonics acquisition to strengthen optical test capabilities.

The Board emphasizes its declassified, majority‑independent structure, annual CEO evaluation, active risk oversight, and stock ownership guidelines. Directors are compensated with cash retainers and time‑vested RSUs, and the Board recommends voting in favor of all five proposals at the May 15, 2026 meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

FormFactor Inc: Amendment to a Schedule 13G/A shows The Vanguard Group reports 0 shares beneficially owned of FormFactor Inc common stock and 0% of the class, reflecting an internal realignment effective January 12, 2026 per SEC Release No. 34-39538.

The filing lists Vanguard's address and states certain subsidiaries will report separately; the reporting person signed the amendment on 03/26/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

FormFactor, Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held virtually on May 15, 2026. The Proxy Statement reviews 2025 performance, governance, board composition, and five shareholder proposals: election of seven directors; an amendment to the Certificate of Incorporation to add officer exculpation; advisory approval of 2025 executive compensation; an increase of 5,000,000 shares to the 2012 Equity Incentive Plan; and ratification of KPMG as independent auditors. The Statement highlights $785 million revenue in 2025, margin-improvement initiatives, a January 2026 restructuring, the Farmers Branch, Texas facility purchase, and the acquisition of Keystone Photonics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

FORMFACTOR INC CEO Mike Slessor reported open-market sales of 10,227 shares of Common Stock. On March 18, 2026, he sold 1,900 shares at $94.10, 5,495 shares at $95.21, and 2,832 shares at $95.73. A footnote states the sales occurred automatically under a Rule 10b5-1 trading plan adopted on August 19, 2025. Following these transactions, he directly holds 460,859 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 144 filing reporting sales of Common stock by Mike Slessor. The filing lists three dispositions: 01/06/2026 sale of 39,606 shares for $2,574,390.00, 01/15/2026 sale of 13,088 shares for $1,005,295.82, and 02/18/2026 sale of 8,664 shares for $815,576.98. The securities previously issued as restricted stock include grants dated 05/07/2024 (3,800 shares) and 08/01/2024 (6,427 shares).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

FORMFACTOR INC Chief Financial Officer Aric Brendan McKinnis reported an open-market sale of 3,462 shares of common stock on March 5, 2026 at $90.42 per share. The transaction occurred automatically under a Rule 10b5-1 trading plan adopted on December 4, 2025, and left him with 11,140 shares of directly owned common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 proposing the sale of common stock. The filing lists multiple restricted-stock grants and an Employee Stock Purchase Plan allocation with grant dates and the following quantities: 580, 391, 580, 359, 341, 535, 96, 580 linked to specific grant dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.92%
Tags
other
-
Rhea-AI Summary

FormFactor Inc. CFO Aric Brendan McKinnis reported equity award activity involving restricted stock units and common shares. On March 2, 2026, 773 restricted stock units were converted into 773 shares of common stock at $0.00 per share as part of an RSU settlement.

On the same date, 193 common shares were disposed of at $99.70 per share to cover tax withholding obligations tied to the vesting of these RSUs. The RSUs were granted on June 2, 2023 and vest in twelve quarterly installments from September 2, 2023 through June 2, 2026, subject to continued employment and certain severance and change‑of‑control arrangements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

FORMFACTOR INC director Brian C. White sold shares in the company. On February 24, 2026, he completed an open-market sale of 2,300 shares of common stock at $100.01 per share. After this transaction, he directly owned 10,556 shares of FORMFACTOR INC common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Formfactor (FORM) SEC filings are available on StockTitan?

StockTitan tracks 64 SEC filings for Formfactor (FORM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Formfactor (FORM)?

The most recent SEC filing for Formfactor (FORM) was filed on April 2, 2026.

FORM Rankings

FORM Stock Data

8.04B
77.30M
Semiconductor Equipment & Materials
Semiconductors & Related Devices
Link
United States
LIVERMORE

FORM RSS Feed